HealthMedicare's international drug-price model

PhRMA sues over Medicare Part B international drug-pricing model

CMS's GLOBE Model, a mandatory Medicare Part B model tying payment for some drugs to prices in other countries (final rule published October 2, 2026), and its companion GUARD Model: implementation, drug lists, industry response, and legal challenges.

Compiled by Previouslyfrom 2 sources, 1 of them official recordEdition of October 26, 2026Checked today, nothing newFollow this story

The story so far, in brief

5 new developments

New developments

CMS first announced the GLOBE Model in December 2025, alongside GUARD, a similar model for Medicare Part D.¹
CMS published the GLOBE final rule on October 2, 2026, with an effective date of November 30, 2026.²
The mandatory model uses international pricing to set a benchmark for calculating some Medicare Part B drug inflation rebates.²^{, 1}
CMS said lower coinsurance under the model would be offered from April 1, 2027, to March 31, 2032.¹
On October 7, 2026, PhRMA sued in federal court in Washington, D.C., arguing the model exceeds CMS's statutory authority.¹

Follow this story to keep your place: next time, this box shows only what's new since your last visit.

The Story So Far

Every milestone in order, with the records and reporting behind it.

2025
December
CMS announces the GLOBE Model for Part B alongside the GUARD Model for Part D.
fiercehealthcare.com